Rankings
▼
Calendar
CRMD FY 2018 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena
CRMD
CorMedix Inc.
$518M
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$429,797
+30.5% YoY
Gross Profit
$33,011
7.7% margin
Operating Income
-$27M
-6250.4% margin
Net Income
-$27M
-6242.4% margin
EPS (Diluted)
$-1.51
Cash Flow
Operating Cash Flow
-$24M
Free Cash Flow
-$24M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$19M
Total Liabilities
$14M
Stockholders' Equity
-$179M
Cash & Equivalents
$18M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$429,797
$329,327
+30.5%
Gross Profit
$33,011
$214,363
-84.6%
Operating Income
-$27M
-$33M
+18.4%
Net Income
-$27M
-$33M
+18.7%
← Q4 2017
All Quarters
Q1 2018 →